Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.
Guazzi
Marco
M
Heart Failure Unit, Cardiopulmonary Laboratory, Department of Medicine and Surgery, University of Milano, San Paolo Hospital, Via A. di Rudinì 8, Milan, Italy. marco.guazzi@unimi.it
D002908:Chronic Disease; D017079:Exercise Tolerance / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D055806:Microvessels / Q000503:physiopathology; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000187:drug effects; D011659:Pulmonary Gas Exchange / Q000187:drug effects
D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors